DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Folprecht G, Gruenberger T, Hartmann JT. et al.
Cetuximab plus FOLFOX6 or cetuximab plus FOLFIRI as neoadjuvant treatment of nonresectable colorectal liver metastases: A randomized multicenter study (CELIM-study).
ASCO Gastrointestinal Cancer Symposium 2009; (Abstr 296): -
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.